Intelligent Bio Solutions announced the debut of its Intelligent Fingerprinting Drug Screening System at the 2023 Workplace Health & Safety Show in Sydney, Australia on September 20th and 21st. The non-invasive, portable system is designed to enable workplace health and safety managers to conduct simple, non-invasive workplace drug testing anytime and almost anywhere, serving as a deterrent against drug abuse and encouraging employees to adhere to health and safety policies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on INBS:
- Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia
- Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
- Intelligent Bio plans to add ketamine, tramadol to fingerprint drug test
- Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights
- Intelligent Bio Solutions reports 2023 EPS ($10.58) vs. ($11.33) last year